Année de création 2011

Pays Etats-Unis

Cambrooke

Cambrooke Therapeutics recognizes the critical nature of managing serious medical disorders through medically based nutrition therapies. The company was acquired in November 2017 by Ajinomoto. Co. Inc, with a
55% IRR for Seventure Partners.